Alfuzosin 10 mg + Dutasteride 0.5 mg Tablet – Brands in India, PCD & Wholesale (Alfuzest-D)
Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Alpha-1 Blocker + 5-Alpha-Reductase Inhibitor
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Alfuzosin + Dutasteride Tablet – Brands in India for PCD Franchise & Wholesale
Looking for an alfuzosin dutasteride tablet brand for your urology range? Trumac Healthcare markets the BPH combination as Alfuzest-D – alfuzosin 10 mg extended-release + dutasteride 0.5 mg in a bilayer tablet (10 x 10) – and alfuzosin alone as Alfuzest-10 (10 x 15), made at WHO-GMP certified partner units, on a monopoly PCD franchise basis and as wholesale stock across India.
Alfuzosin is the alpha-blocker urologists choose when blood-pressure effects matter; with dutasteride it covers men with an enlarged prostate. Both are core products of the urology & nephrology PCD franchise. Trumac Healthcare has worked since 2007 and supplies more than 4000 franchise partners; no franchise fee, minimum first order ₹25,000.
BPH range
- Alfuzest-D – alfuzosin 10 mg ER + dutasteride 0.5 mg bilayer, 10 x 10
- Alfuzest-10 – alfuzosin 10 mg prolonged release, 10 x 15
- Trutam-D – tamsulosin 0.4 mg + dutasteride 0.5 mg
- Silocam-D8 – silodosin 8 mg + dutasteride 0.5 mg
- Dutamac-0.5 – dutasteride alone
- Full range: urology & nephrology PCD franchise
Ways to work with us
- PCD pharma franchise – alfuzosin + dutasteride tablets under our brand on a monopoly basis for your area, with visual aids and promotional material
- Wholesale supply – stock for distributors, stockists and hospital suppliers across India, against drug licence and GST
- Own-brand (third-party) enquiries – share the composition, pack and quantity and we will confirm availability and send a quotation
How to start
- Send your requirement on WhatsApp – product, franchise or wholesale, quantity and your area
- Receive the price list and monopoly terms (no franchise fee; minimum first order ₹25,000)
- Confirm the order and pay by NEFT, RTGS or IMPS
- Goods are dispatched once payment reflects, with the docket number for tracking
Questions buyers ask
Which alfuzosin + dutasteride tablet brands are available in India for PCD franchise?
Alfuzest-D from Trumac Healthcare (alfuzosin 10 mg ER + dutasteride 0.5 mg bilayer tablet, 10 x 10), made at WHO-GMP certified partner units, on a monopoly PCD franchise basis across India.
Do you supply alfuzosin-dutasteride wholesale?
Yes, to distributors and stockists with a valid drug licence. Share quantity and location for the rate.
Is alfuzosin alone available?
Yes – Alfuzest-10, alfuzosin 10 mg prolonged-release tablets, 10 x 15.
Can I take the urology range alone on monopoly?
Yes – the urology & nephrology division can be taken for your district on its own or with the general range.
Enquiry: Share your alfuzosin requirement – franchise or wholesale, with quantity and location. WhatsApp +91 90416 77932.
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the general range products product list. No franchise fee; minimum first order ₹25,000 – cost and documents.
Therapeutic Indications
- Moderate-to-severe lower urinary tract symptoms (LUTS) of BPH with enlarged prostate
- BPH where alpha-blocker monotherapy is inadequate
- Long-term reduction of prostate volume and acute urinary retention risk
- Prevention of BPH progression
Mechanism of Action
Alfuzosin selectively blocks alpha-1A/1D adrenergic receptors in the prostate, bladder neck and urethra, relaxing smooth muscle tone for immediate symptom relief. Dutasteride inhibits both type 1 and type 2 isoforms of 5-alpha-reductase, dramatically reducing serum and intra-prostatic DHT levels, which over months produces apoptosis of androgen-dependent prostatic tissue and a 20–25% reduction in prostate volume.
Dosage & Administration
- Adults: one tablet once daily, taken at the same time each day with or without food.
- Swallow whole.
- Long-term therapy required for full Dutasteride benefit (6–12 months for prostate-volume reduction).
Side Effects
- Alfuzosin: dizziness, postural hypotension, headache, fatigue.
- Dutasteride: decreased libido, erectile dysfunction, ejaculation disorders, gynaecomastia, breast tenderness.
- Combined regimen may increase ejaculatory dysfunction frequency.
Contraindications
- Hypersensitivity to either component or other 5-alpha-reductase inhibitors (finasteride).
- Women — particularly pregnant or potentially pregnant women — must not handle leaking capsules (teratogenicity risk).
- Severe hepatic impairment.
- Concomitant potent CYP3A4 inhibitors.
- Not for use in children.
- Inform ophthalmologist before cataract surgery (IFIS risk).
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet?
Available pack sizes include: 10 x 10 (Alu Alu).
What is the MRP / trade price for Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet?
MRPs range from ₹1650 to ₹1650 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Alfuzosin 10 mg Extended Release + Dutasteride 0.5 mg Tab Tablet?